Equitec Proprietary Markets’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Equitec Proprietary Markets’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-95,600	Closed	-$211K	–	143
2023 Q2	$211K	Buy	+95,600	New	+$198K	0.06%	63

Equitec Proprietary Markets's PRTK Position: Q3 2023 in Review

Equitec Proprietary Markets sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 95,600 shares — an estimated $211K sold.

Equitec Proprietary Markets first reported a position in PRTK in Q2 2023 and held it in 1 quarter. The position peaked at $211K in Q2 2023. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

Equitec Proprietary Markets reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Equitec Proprietary Markets sold 95,600 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $211K.
Equitec Proprietary Markets first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2023 and held it in 1 quarter.
Equitec Proprietary Markets's Paratek Pharmaceuticals, Inc. position peaked at $211K in Q2 2023.
0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on Equitec Proprietary Markets's 13F filing for Q3 2023, filed 17 Oct 2023.